Advertisement

Topics

Cerenis Therapeutics acquires Lypro Biosciences

03:16 EST 9 Nov 2017 | Pharmaceutical Business Review

Cerenis Therapeutics has acquired Lypro Biosciences to expanding its HDL strategy into immuno-oncology and chemotherapeutic drug delivery.

Original Article: Cerenis Therapeutics acquires Lypro Biosciences

NEXT ARTICLE

More From BioPortfolio on "Cerenis Therapeutics acquires Lypro Biosciences"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Drug Delivery
<!--LGfEGNT2Lhm-->Drug delivery is the method or process of administering a pharmaceutical compound to achieve a therapeutic effect in humans or animals.  <!--LGfEGNT2Lhm-->Drug delivery technologies are <!--LGfEGNT2Lhm-->patent pr...